Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Price

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Sports Medicine|November 28, 2015
The impact of diagnosis: measuring the psychological response to being diagnosed with serious or potentially lethal cardiac disease in young competitive athletesIrfan M Asif, David E Price, Alex Ewing, et al.
Diabetes & Metabolic Syndrome|April 5, 2020
Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UKNatasha Shrikrishnapalasuriyar, Ayesha Shaikh, Aliya Mohd Ruslan, et al.
Heart Rhythm|December 10, 2013
Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletesDavid E Price, Andrew McWilliams, Irfan M Asif, et al.
Diabetes & Metabolic Syndrome|July 15, 2018
Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinicDavid M Williams, Natasha Shrikrishnapalasuriyar, Waheeba Syed, et al.
Primary Care Diabetes|July 14, 2009
Are blood pressure levels taken during a secondary care diabetic clinic likely to be higher than when measured in primary care?Caroline J Brooks, Ting S Tang, David V Ford, et al.
Diabetes Care|April 29, 2011
Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care 2011;34:262-267Jeffrey W Stephens, Julie E Carman, Caroline J Brooks, et al.
British Journal of Sports Medicine|September 24, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|September 7, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future DirectionsJonathan A Drezner, Francis G OʼConnor, Kimberly G Harmon, et al.
British Journal of Sports Medicine|October 7, 2016
Infographic: AMSSM position statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations and future directionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Current Sports Medicine Reports|September 13, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations and Future DirectionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Sports Medicine|November 28, 2015
The impact of diagnosis: measuring the psychological response to being diagnosed with serious or potentially lethal cardiac disease in young competitive athletesIrfan M Asif, David E Price, Alex Ewing, et al.
Diabetes & Metabolic Syndrome|April 5, 2020
Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UKNatasha Shrikrishnapalasuriyar, Ayesha Shaikh, Aliya Mohd Ruslan, et al.
Heart Rhythm|December 10, 2013
Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletesDavid E Price, Andrew McWilliams, Irfan M Asif, et al.
Diabetes & Metabolic Syndrome|July 15, 2018
Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinicDavid M Williams, Natasha Shrikrishnapalasuriyar, Waheeba Syed, et al.
Primary Care Diabetes|July 14, 2009
Are blood pressure levels taken during a secondary care diabetic clinic likely to be higher than when measured in primary care?Caroline J Brooks, Ting S Tang, David V Ford, et al.
Diabetes Care|April 29, 2011
Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care 2011;34:262-267Jeffrey W Stephens, Julie E Carman, Caroline J Brooks, et al.
British Journal of Sports Medicine|September 24, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|September 7, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future DirectionsJonathan A Drezner, Francis G OʼConnor, Kimberly G Harmon, et al.
British Journal of Sports Medicine|October 7, 2016
Infographic: AMSSM position statement on cardiovascular preparticipation screening in athletes: Current evidence, knowledge gaps, recommendations and future directionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Current Sports Medicine Reports|September 13, 2016
AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations and Future DirectionsJonathan A Drezner, Francis G O'Connor, Kimberly G Harmon, et al.
Pageof 2